Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Comparative Effectiveness Necessary To Weigh New Drugs Against Old Ones, Opinion Piece Says
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it"s a real advance on what"s already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece. According to Friedman, "Doctors and patients alike are inundated by drug company marketing." Friedman states he has seen "scores of patients" who are "eager to get the latest antidepressant or mood stabilizer that promised them tranquility on their TV screens." He continues that these new treatments are not necessarily better than older, proven treatments. Comparative effectiveness research would allow "head-to-head trials comparing new and standard treatments," which is why the practice has "provoked strong resistance from the makers of drugs and devices who fear that their fancy new products may not be any better than current ones," according to Friedman. He concludes, "I"d opt for an old drug with a known track record of efficacy and safety over an expensive newcomer with no added benefit -- any day of the week" (Friedman, New York Times, 5/19).
generic viagra online
Continuing VA Endoscope Contamination Problem Unacceptable, Says The American Legion
The national commander of the nation"s largest veterans service organization is expressing outrage at continuing instances of VA medical personnel exposing their patients to infectious diseases.
News of the day
Council Recognises Champions Of Pharmacy
Two pharmacists, and one non-pharmacist, have been recognised by the Council of the Royal
Medical Devices

Appeal For Cancer Patients To Trial New Nail Damage Remedy

The search is on for fifty cancer patients undergoing chemo or radiotherapy to trial an innovative, natural cosmetic product, Evonail, aimed at reversing the damage done to cracked or broken nails during anti-cancer treatments. Evolife"s full range of support care products, including Evonail, are regularly used in France and in over 16 countries in the world, but they have only recently been launched in the UK through the http://www.feelbetterduringchemo.com website, operated by Feel Better Ltd. In 2006, a study showed that 20 to 25% of nail alterations were diagnosed as side effects of chemotherapy. Cracked and brittle nails can be a painful and debilitating side-effect of cancer and radiotherapy treatment making simple tasks like turning the page of a magazine excruciating. Anyone wanting to volunteer for the trial simply needs to send an email to contact@feelbetterduringchemo.com. Anti-cancer treatments can cause nails to become dehydrated, often making them become darkened, yellow, brittle or cracked. They may also develop vertical lines or bands. Evonail helps restore the nails" moisture levels, making them stronger whilst reducing cracks and flakes. Speaking from the ASCO World Oncology Congress in Orlando where Evolife was being launched in the US, Charles Felgate, joint Managing Director of Feel Better Ltd, said: "Up until now cancer patients have had to suffer in silence with little relief from the distressing side effects of chemo and radiotherapy. Now Evonail brings real relief to people who find the simplest of tasks painful because of their brittle nails." The effectiveness of the product on chemotherapy patients was discovered when Dr Geraldine Reynaert, a French dermatologist, was transferred to an oncology clinic in Marseille. She noticed that nail problems caused by cancer treatments were similar to those suffered by the psoriasis patients she had treated previously. She decided therefore to try out the Evaux Laboratories product she had been using. Dr Reynaert said: "In light of the outstanding results achieved, I informed the Evaux Laboratoires research and development team who began to work on a specifically adapted Totum Lithium formula* which eventually became EVONAIL. I then tested this product, successfully, on numerous patients." With scientific papers from the "Journal of Neuro-Oncology" backing up her findings, Dr Raeynart has continued to help Evolife Laboratoires with their research into various topics relating to the different forms of cutaneous and cutaneo-mucous side effects in chemotherapy and radiotherapy. She has actively taken part in the development of the 10 specific EVOLIFE products that are now available in the UK." Dr Reynaert isn"t the only doctor to use the product. Dr Radu Vanica, from the Medical Oncology Department of Argenteuil Hospital, Paris, said: "We have used Evonail on patients presenting side effects on their nails after having undergone anti-tumour treatments. The efficiency of the product and the visible improvements were remarkable." Dr Sylvie Delanian from the Hospital Saint Louis in Paris added: "Please allow me to express my sincere gratitude for the Evolife products that are used to treat cancer patients undergoing chemotherapy, particularly Evonail. Patients being treated with breast, prostate and lung cancer were happy to be rid of the handicap affecting their finger and toe nails." The Evolife product range, available exclusively from Feel Better Ltd, has been designed to make unpleasant cutaneous side effects of chemo and radiotherapy treatments more bearable. The collection includes gels, sprays and creams, and is already used by a number of leading oncologists and cancer treatment centres in France and worldwide, with remarkable results. Evolife provides solutions to problems that previously had few answers. These include cracked and broken nails (Evonail); flaking and broken skin (Evoskin); mouth ulcers (Evomucy), dry mouth (Evodry) and body odour (Evodeo), to name but a few. * Totum Lithium describes the unique composition of Evaux-les-Bains spring water Feel Better Ltd


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009